Blackstone’s Billion‑Dollar Bet: Why the RCB Acquisition Signals a New Era of Private Equity Power in Cricket’s Indian Premier League02/07/2026
Agriculture Digital Sovereignty Alliance Launches Digital Asset Case Study Program at St. Andrew’s Episcopal School02/06/2026
Agriculture American Banker Reveals New Honorees for The Most Innovative People in Finance and Innovation of the Year01/06/2026
News Florida Property Tax Reform Impact Could Wipe Out 60% of Homeowner Bills — But at What Cost?31/05/2026
Brexit fees on food imports ‘will increase prices’By News Team04/04/2024 New import regulations are likely to increase food prices in British shops. The Brexit-related Common…
Nationwide ad banned over ‘not closing branches’ claimBy News Team03/04/2024 A TV advert for Nationwide that claimed the building society was not closing branches has…
BT to convert 2,000 payphones into advertising screensBy News Team28/03/2024 BT is to convert payphones into digital hubs in more than 200 towns and cities…
Fashion brands agree changes to eco-friendly claimsBy News Team27/03/2024 Three UK fashion brands have agreed to change the way they present their environmental credentials.…
Further easing of grocery price inflationBy News Team26/03/2024 Price rises in the supermarkets are continuing to come down but consumers are still on…
EU launches competition probe into Apple, Google and MetaBy News Team25/03/2024 The European Union is to examine three of the biggest tech firms over possible breaches…
Next profit climbs to record highBy News Team21/03/2024 High street clothing and homeware retailer Next has reported 5% growth in profit for the…
UK credit card debt up 9.7%By News Team18/03/2024 The amount owed on UK credit cards increased last year as household finances came under…
Swisscom to acquire Vodafone ItalyBy News Team15/03/2024 Vodafone has agreed to sell its Italian operations to Swisscom for €8bn (£6.8bn) in cash.…
AstraZeneca expands rare disease pipeline with Amolyt Pharma acquisitionBy News Team14/03/2024 Astrazeneca has agreed to acquire Amolyt Pharma, a clinical-stage biotech with a focus on rare…
